Company intelligence / Profile preview
DEMECAN
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
Overview
DEMECAN is a leading German pharmaceutical company specializing in the entire value chain of medical cannabis, from cultivation and processing to distribution. As one of the few entities licensed by the Federal Institute for Drugs and Medical Devices (BfArM) to produce medical cannabis in Germany, the company operates a state-of-the-art GMP-certified manufacturing facility in Saxony. Their product portfolio includes high-quality cannabis flowers, full-spectrum extracts, and Dronabinol, aimed at treating chronic pain and other complex conditions. DEMECAN focuses on ensuring a reliable supply of medical-grade cannabinoids to pharmacies and wholesalers across the European market. The company is vertically integrated, combining pharmaceutical expertise with advanced indoor cultivation technology to meet strict regulatory standards.
- Therapeutic areas
- GastroenterologyPsychiatryNeurology
- Modalities
- Small moleculeBotanical extractPlant extract
- Industry
- Pharma
Drug pipeline
28 assets27 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on DEMECAN.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DEMECAN.